Showing results (1811-1820 of 31,365) with videos related to
Sort By:
Pageof 3,137
Journal of Medicinal Chemistry|February 26, 2000
Heteroarylmethoxyphenylalkoxyiminoalkylcarboxylic acids as leukotriene biosynthesis inhibitorsT Kolasa, D E Gunn, P Bhatia, et al.Journal of Medicinal Chemistry|February 26, 2000
A new class of conformationally rigid analogues of 4-amino-5-halopentanoic acids, potent inactivators of gamma-aminobutyric acid aminotransferaseJ Qiu, R B SilvermanJournal of Medicinal Chemistry|October 3, 1999
Design and fast synthesis of C-terminal duplicated potent C(2)-symmetric P1/P1'-modified HIV-1 protease inhibitorsM Alterman, H O Andersson, N Garg, et al.Journal of Medicinal Chemistry|October 3, 1999
Crystallographic analysis of the binding modes of thiazoloisoindolinone non-nucleoside inhibitors to HIV-1 reverse transcriptase and comparison with modeling studiesJ Ren, R M Esnouf, A L Hopkins, et al.Journal of Medicinal Chemistry|October 3, 1999
Synthesis, pharmacological and biophysical characterization, and membrane-interaction QSAR analysis of cationic amphiphilic model compoundsC D Klein, M Klingmüller, C Schellinski, et al.Journal of Medicinal Chemistry|October 3, 1999
Novel lipoamino acid- and liposaccharide-based system for peptide delivery: application for oral administration of tumor-selective somatostatin analoguesI Tóth, J P Malkinson, N S Flinn, et al.Journal of Medicinal Chemistry|October 9, 1999
High-resolution NMR and computer modeling studies of the cannabimimetic aminoalkylindole prototype WIN-55212-2X Q Xie, X W Han, J Z Chen, et al.Journal of Medicinal Chemistry|October 9, 1999
Inhibitors of the C(2)-symmetric HIV-1 protease: nonsymmetric binding of a symmetric cyclic sulfamide with ketoxime groups in the P2/P2' side chainsJ Hultén, H O Andersson, W Schaal, et al.Journal of Medicinal Chemistry|October 9, 1999
Discovery of potent and selective SH2 inhibitors of the tyrosine kinase ZAP-70C B Vu, E G Corpuz, T J Merry, et al.Journal of Medicinal Chemistry|October 9, 1999
Synthesis and structure-activity relationships of the (alkylamino)piperidine-containing BHAP class of non-nucleoside reverse transcriptase inhibitors: effect of 3-alkylpyridine ring substitutionM J Genin, T J Poel, P D May, et al.Pageof 3,137